HA14-1 is able to reconstitute the impaired mitochondrial pathway of apoptosis in renal cell carcinoma cell lines

Cellular Oncology

Volumn 30, Issue 5, 2008, Pages 419-433

  Heikaus, Sebastian ^a   Van Den Berg, Linda ^a   Kempf, Tobias ^a   Mahotka, Csaba ^a   Gabbert, Helmut Erich ^a   Ramp, Uwe ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Anticancer drugs; Apoptosis; BCL 2; Renal cell carcinoma; TRAIL

Indexed keywords

2 AMINO 6 BROMO 4 (1 CYANO 2 ETHOXY 2 OXOETHYL) 4H CHROMENE 3 CARBOXYLIC ACID ETHYL ESTER; BETULIC ACID; CASPASE 8; CASPASE 9; ETOPOSIDE; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CELL LINE; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZOPYRANS; BLOTTING, WESTERN; CASPASE 8; CASPASE 9; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; HUMANS; MITOCHONDRIA; NITRILES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRITERPENES;

EID: 52449125388     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/693095     Document Type: Article

References (51)

1. U. Ramp, E. Caliskan, C. Mahotka, A. Krieg, S. Heikaus, H.E. Gabbert and C.D. Gerharz, Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage, British Journal of Cancer 88 (2003), 1800-1807.
2. U. Ramp, C. Mahotka, T. Kalinski, E. Ebel, H.E. Gabbert and C.D. Gerharz, Topotecan (Hycamtin) responsiveness in human renal carcinoma cell lines of the clear cell and papillary types, Anticancer Research 21 (2001), 3509-3517.
3. U. Ramp, M. Dejosez, C. Mahotka, B. Czarnotta, T. Kalinski, M. Wenzel, I. Lorenz, M. Muller, P. Krammer, H.E. Gabbert and C.D. Gerharz, Deficient activation of CD95 (APO-1/Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma, British Journal of Cancer 82 (2000), 1851-1859.
4. M. Dejosez, U. Ramp, C. Mahotka, A. Krieg, H. Walczak, H.E. Gabbertand and C.D. Gerharz, Sensitivity to TRAIL/APO-2L-mediated apoptosis in human renal cell carcinomas and its enhancement by topotecan, Cell Death and Differentiation 7 (2000), 1127-1136.
5. C. Falschlehner, C.H. Emmerich, B. Gerlach and H. Walczak, TRAIL signalling: Decisions between life and death, International Journal of Biochemistry and Cell Biology 39 (2007), 1462-1475.
6. J. Skommer, D. Wlodkowic and A. Deptala, Larger than life: Mitochondria and the Bcl-2 family, Leukemia Research 31 (2007), 277-286.
7. A.G. Yakovlev, S. Di Giovanni, G. Wang, W. Liu, B. Stoica and A.I. Faden, BOK and NOXA are essential mediators of p53-dependent apoptosis, Journal of Biological Chemistry 279 (2004), 28367-28374.
8. M.T. Hemann, J.T. Zilfou, Z. Zhao, D.J. Burgess, G.J. Hannon and S.W. Lowe, Suppression of tumorigenesis by the p53 target PUMA, Proceedings of the National Academy of Sciences of the United States of America 101 (2004), 9333-9338.
9. N.G. Iyer, S.F. Chin, H. Ozdag, Y. Daigo, D.E. Hu, M. Cariati, K. Brindle, S. Aparicio and C. Caldas, p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels, Proceedings of the National Academy of Sciences of the United States of America 101 (2004), 7386-7391.
10. E.A. Slee, S.A. Keogh and S.J. Martin, Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c release, Cell Death and Differentiation 7 (2000), 556-565.
11. K.W. Wagner, I.H. Engels and Q.L. Deveraux, Caspase-2 can function upstream of bid cleavage in the TRAIL apoptosis pathway, Journal of Biological Chemistry 279 (2004), 35047-35052.
12. C. Du, M. Fang, Y. Li, L. Li and X. Wang, Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition, Cell 102 (2000), 33-43.
13. A.M. Verhagen, P.G. Ekert, M. Pakusch, J. Silke, L.M. Connolly, G.E. Reid, R.L. Moritz, R.J. Simpson and D.L. Vaux, Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins, Cell 102 (2000), 43-53.
14. K. Kuribayashi, P.A. Mayes and W.S. El-Deiry, What are caspases 3 and 7 doing upstream of the mitochondria?, Cancer Biology and Therapy 5 (2006), 763-765.
15. S.A. Lakhani, A. Masud, K. Kuida, G.A. Porter Jr., C.J. Booth, W.Z. Mehal, I. Inayat and R.A. Flavell, Caspases 3 and 7: key mediators of mitochondrial events of apoptosis, Science 311 (2006), 847-851.
16. C.F. Lin, C.L. Chen, W.T. Chang, M.S. Jan, L.J. Hsu, R.H. Wu, M.J. Tang, W.C. Chang and Y.S. Lin, Sequential caspase-2 and caspase-8 activation upstream of mitochondria during ceramide and etoposide-induced apoptosis, Journal of Biological Chemistry 279 (2004), 40755-40761.
17. L. Lalier, P.F. Cartron, P. Juin, S. Nedelkina, S. Manon, B. Bechinger and F.M. Vallette, Bax activation and mitochondrial insertion during apoptosis, Apoptosis 12 (2007), 887-896.
18. S. Wang and W.S. El-Deiry, TRAIL and apoptosis induction by TNF-family death receptors, Oncogene 22 (2003), 8628-8633.
19. A. Villunger, E.M. Michalak, L. Coultas, F. Mullauer, G. Bock, M.J. Ausserlechner, J.M. Adams and A. Strasser, A p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa, Science 302 (2003), 1036-1038.
20. S. Fulda, C. Friesen, M. Los, C. Scaffidi, W. Mier, M. Benedict, G. Nunez, P.H. Krammer, M.E. Peter and K.M. Debatin, Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors, Cancer Research 57 (1997), 4956-4964.
21. S. Fulda, I. Jeremias, H.H. Steiner, T. Pietsch and K.M. Debatin, Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells, International Journal of Cancer 82 (1999), 435-441.
22. J.L. Wang, D. Liu, Z.J. Zhang, S. Shan, X. Han, S.M. Srinivasula, C.M. Croce, E.S. Alnemri and Z. Huang, Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells, Proceedings of the National Academy of Sciences of the United States of America 97 (2000), 7124-7129.
23. J.D. Lickliter, N.J. Wood, L. Johnson, G. McHugh, J. Tan, F. Wood, J. Cox and N.W. Wickham, HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death, Leukemia 17 (2003), 2074-2080.
24. M.F. van Delft, A.H. Wei, K.D. Mason, C.J. Vandenberg, L. Chen, P.E. Czabotar, S.N. Willis, C.L. Scott, C.L. Day, S. Cory, J.M. Adams, A.W. Roberts and D.C. Huang, The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized, Cancer Cell 10 (2006), 389-399.
25. J.D. Lickliter, N.J. Wood, L. Johnson, G. McHugh, J. Tan, F. Wood, J. Cox and N.W. Wickham, HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death, Leukemia 17 (2003), 2074-2080.
26. C.D. Gerharz, R. Moll, S. Storkel, U. Ramp, W. Thoenes and H.E. Gabbert, Ultrastructural appearance and cytoskeletal architecture of the clear, chromophilic, and chromophobe types of human renal cell carcinoma in vitro, American Journal of Pathology 142 (1993), 851-859.
27. C.D. Gerharz, U. Ramp, J. Olert, R. Moll, S. Storkel, N. Marx and H.E. Gabbert, Cytomorphological, cytogenetic, and molecular biological characterization of four new human renal carcinoma cell lines of the clear cell type, Virchows Archiv 424 (1994), 403-409.
28. M. Leist, C. Volbracht, E. Fava and P. Nicotera, 1-Methyl-4- phenylpyridinium induces autocrine excitotoxicity, protease activation, and neuronal apoptosis, Molecular Pharmacology 54 (1998), 789-801.
29. W. Roth and J.C. Reed, FLIP protein and TRAIL-induced apoptosis, Vitamines and Hormones 67 (2004), 189-206.
30. C. Hao, F. Beguinot, G. Condorelli, A. Trencia, E.G. Van Meir, V.W. Yong, I.F. Parney, W.H. Roa and K.C. Petruk, Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apoptosis in human malignant glioma cells, Cancer Research 61 (2001), 1162-1170.
31. C. Xiao, B.F. Yang, N. Asadi, F. Beguinot and C. Hao, Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells, Journal of Biological Chemistry 277 (2002), 25020-25025.
32. C.F. Lin, C.L. Chen, W.T. Chang, M.S. Jan, L.J. Hsu, R.H. Wu, Y.T. Fang, M.J. Tang, W.C. Chang and Y.S. Lin, Bcl-2 rescues ceramide- and etoposide-induced mitochondrial apoptosis through blockage of caspase-2 activation, Journal of Biological Chemistry 280 (2005), 23758-23765.
33. G.R. Jung, K.J. Kim, C.H. Choi, T.B. Lee, S.I. Han, H.K. Han and S.C. Lim, Effect of betulinic acid on anticancer drug-resistant colon cancer cells, Basic & Clinical Pharmacology & Toxicology 101 (2007), 277-285.
34. M. Irmler, M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J.L. Bodmer, M. Schroter, K. Burns, C. Mattmann, D. Rimoldi, L.E. French and J. Tschopp, Inhibition of death receptor signals by cellular FLIP, Nature 388 (1997), 190-195.
35. C. Scaffidi, I. Schmitz, J. Zha, S.J. Korsmeyer, P.H. Krammer and M.E. Peter, Differential modulation of apoptosis sensitivity in CD95 type I and type II cells, Journal of Biological Chemistry 274 (1999), 22532-22538.
36. G. Condorelli, G. Vigliotta, A. Cafieri, A. Trencia, P. Andalo, F. Oriente, C. Miele, M. Caruso, P. Formisano and F. Beguinot, PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis, Oncogene 18 (1999), 4409-4415.
37. M.J. Fisher, A.K. Virmani, L. Wu, R. Aplenc, J.C. Harper, S.M. Powell, T.R. Rebbeck, D. Sidransky, A.F. Gazdar and W.S. El-Deiry, Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer, Clinical Cancer Research 7 (2001), 1688-1697.
38. W.S. Park, J.H. Lee, M.S. Shin, J.Y. Park, H.S. Kim, Y.S. Kim, C.H. Park, S.K. Lee, S.H. Lee, S.N. Lee, H. Kim, N.J. Yoo and J.Y. Lee, Inactivating mutations of KILLER/DR5 gene in gastric cancers, Gastroenterology 121 (2001), 1219-1225.
39. L. Bin, J. Thorburn, L.R. Thomas, P.E. Clark, R. Humphreys and A. Thorburn, Tumor-derived mutations in the TRAIL receptor DR5 inhibit TRAIL signaling through the DR4 receptor by competing for ligand binding, Journal of Biological Chemistry 282 (2007), 28189-28194.
40. E.A. Slee, C. Adrain and S.J. Martin, Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis, Journal of Biological Chemistry 276 (2001), 7320-7326.
41. A.D. Guerrero, M. Chen and J. Wang, Delineation of the caspase-9 signaling cascade, Apoptosis 13 (2008), 177-186.
42. M.A. McDonnell, D. Wang, S.M. Khan, M.G. Vander Heiden and A. Kelekar, Caspase-9 is activated in a cytochrome c-independent manner early during TNFalpha-induced apoptosis in murine cells, Cell Death and Differentiation 10 (2003), 1005-1015.
43. M. Gyrd-Hansen, T. Farkas, N. Fehrenbacher, L. Bastholm, M. Høyer-Hansen, F. Elling, D. Wallach, R. Flavell, G. Kroemer, J. Nylandsted and M. Jäättelä, Apoptosome-independent activation of the lysosomal cell death pathway by caspase-9, Molecular and Cellular Biology 26 (2006), 7880-7891.
44. S. Desagher, A. Osen-Sand, S. Montessuit, E. Magnenat, F. Vilbois, A. Hochmann, L. Journot, B. Antonsson and J.C. Martinou, Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase-8. Molecular Cell 8 (2001), 601-611.
45. M.C. Gerhard, N. Zantl, G. Weirich, S. Schliep, B. Seiffert and G. Hacker, Functional evaluation of the apoptosome in renal cell carcinoma, British Journal of Cancer 89 (2003), 2147-2154.
46. J.M. Doshi, D. Tian and C. Xing, Ethyl-2-amino-6-bromo-4-(1-cyano-2- ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), a prototype small-molecule antagonist against antiapoptotic Bcl-2 proteins, decomposes to generate reactive oxygen species that induce apoptosis, Molecular Pharmacology 4 (2007), 919-928.
47. D. Tian, S.G. Das, J.M. Doshi, J. Peng, J. Lin and C. Xing, sHA 14-1, a stable and ROS-free antagonist against anti-apoptotic Bcl-2 proteins, bypasses drug resistances and synergizes cancer therapies in human leukemia cell, Cancer Letters 259 (2008), 198-208.
48. A.A. Chaudhari, J.W. Seol, S.J. Kim, Y.J. Lee, H.S. Kang, I.S. Kim, N.S. Kim and S.Y. Park, Reactive oxygen species regulate Bax translocation and mitochondrial transmembrane potential, a possible mechanism for enhanced TRAIL-induced apoptosis by CCCP, Oncology of Reproduction 18 (2007), 71-76.
49. K. Izeradjene, L. Douglas, D.M. Tillman, A.B. Delaney and J.A. Houghton, Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines, Cancer Research 65 (2005), 7436-7445.
50. I. Perez-Cruz, J.M. Cárcamo and D.W. Golde, Caspase-8 dependent TRAIL-induced apoptosis in cancer cell lines is inhibited by vitamin C and catalase, Apoptosis 12 (2007), 225-234.
51. S. Heikaus, E. Casliskan, C. Mahotka, H.E. Gabbert and U. Ramp, Differential gene expression in anticancer drug- and TRAIL-mediated apoptosis in renal cell carcinomas, Apoptosis 12 (2007), 1645-1657.